Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for clinical prognosis in optic neuritis
IRCT20200719048138N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fluoxetine in optic neuritis (ON), sponsored by Iran University of Medical Sciences. Started Oct 2019; status: completed.
02
Drugs
fluoxetine
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on IRCT20200719048138N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200719048138N1.